Sort   by:  
 Page size 
UnknownSubstrate Promiscuity of a Paralytic Shellfish Toxin Amidinotransferase.
Not available
S-EPMC7362304 | biostudies-literature
UnknownExtremely rare variants reveal patterns of germline mutation rate heterogeneity in humans.
Not available
S-EPMC6138700 | biostudies-literature
UnknownMutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
Not available
S-EPMC7159804 | biostudies-literature
UnknownOptimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight.
Not available
S-EPMC7171946 | biostudies-literature
UnknownDifferential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Not available
S-EPMC10973899 | biostudies-literature
UnknownComparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Not available
S-EPMC10973908 | biostudies-literature
UnknownAssociation of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
Not available
S-EPMC10973909 | biostudies-literature
UnknownBenefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
Not available
S-EPMC9208859 | biostudies-literature
UnknownDesign and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Not available
S-EPMC6888890 | biostudies-literature
UnknownDesign and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Not available
S-EPMC6889917 | biostudies-literature
Sort   by:  
 Page size